00000nam 2200000zi 4500 9.912486 CaOODSP 20220620141139 m o d f cr mn||||||||| 220620t19831983onca ob f000 0 eng d 0662525329 (bilingual ; print) CaOODSP eng rda CaOODSP n-cn--- RG15-2/1983E-PDF RG15-2/1983-PDF Compulsory licensing of pharmaceuticals : a review of Section 41 of the Patent Act. [Ottawa] : Consumer and Corporate Affairs Canada = Consommation et corporations Canada, 1983. ©1983 1 online resource (ix, 64 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Octroi obligatoire de licences dans le domaine des produits pharmaceutiques : révision de l'article 41 de la Loi sur les brevets. "June 1983." Digitized edition from print [produced by Innovation, Science and Economic Development Canada]. Includes bibliographical references. "This paper reviews the effect of the 1969 Patent Act revisions on the drug industry in Canada. It analyzes how these changes have affected the activities of the pharmaceutical industry, the prices of prescription drugs and the current investment climate in Canada. It also considers, in line with government policy to stimulate high technology industry, a number of possible changes to the Patent Act that may improve the investment climate for major pharmaceutical firms while assuring a continued supply of reasonably priced drugs for Canadians"--Introduction, page 1. Canada. Patent Act. Pharmaceutical industry Canada. Drugs Prices Canada. Compulsory licensing of patents Canada. Canada. Consumer and Corporate Affairs Canada, issuing body. Octroi obligatoire de licences dans le domaine des produits pharmaceutiques : (CaOODSP)9.912487 PDF 4.24 MB https://publications.gc.ca/collections/collection_2022/isde-ised/RG15-2-1983-eng.pdf